MBS303, a Novel 2:1 CD20×CD3 Bispecific Antibody, Demonstrated
mbs303MBS303MSC303 (MBS303 as the intravenous formulation, MSC303 as the subcutaneous formulation) is an innovative CD20CD3 T-cell engager. MBS303 has initiated clinical trials915cdembs303cd20cd3b mbs303t